Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Download Citation

Article Source: Dacarbazine and the Agonistic TRAIL Receptor-2 Antibody Lexatumumab Induce Synergistic Anticancer Effects in Melanoma
Engesæter B, Engebraaten O, Flørenes VA, Mælandsmo GM (2012) Dacarbazine and the Agonistic TRAIL Receptor-2 Antibody Lexatumumab Induce Synergistic Anticancer Effects in Melanoma. PLoS ONE 7(9): e45492. doi: 10.1371/journal.pone.0045492

Download the article citation in the following formats: